us national antiviral stockpile inadequate

CDC's Strategic National Stockpile (SNS) contains approximately: 39.7 million regimens of oseltamivir capsules (Tamiflu), 9,279 regimens of oral suspension oseltamivir, and 10.3 million regimens of zanamivir (Relenza).

In addition to the antivirals received from the federal portion of the stockpile, according to HHS, as of September 10, 2009, state and local jurisdictions have stockpiled over 25 million treatment courses of antivirals, which is about five million short of the national goal.

Combining the federal allocations received by states with states' purchases, 13 states do not currently have enough antivirals to cover 20 percent of their population And another 11 states have only enough antivirals to cover between 20 and 25 percent of their population (combining their federal allocation and state purchases)

As of November 2008, there were just over 3.8 million regimens of pediatric antiviral formulations in the federal stockpile to treat a potentialpandemic flu for the nation's 73.6 million children. The government has not set any target for stockpiling pediatric antivirals, even though children and adolescents are known to often be disproportionately affected by contagious respiratory illnesses, and have been especially affected by the current H1N1 outbreak.